Terms: = Ovarian cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
317 results:
1. Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in ovarian Epithelial cancer-Relation to Tumour Characteristics and Impact on Prognosis.
Stout A; Facey N; Bhatnagar A; Rice K; Berditchevski F; Kearns D; Metcalf A; Elghobashy A; Shaaban AM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674108
[TBL] [Abstract] [Full Text] [Related]
2. Sensitization of cancer cells to paclitaxel-induced apoptosis by canagliflozin.
Huang H; Kung FL; Huang YW; Hsu CC; Guh JH; Hsu LC
Biochem Pharmacol; 2024 May; 223():116140. PubMed ID: 38513740
[TBL] [Abstract] [Full Text] [Related]
3. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer.
Xiang SY; Li QK; Yang Z; Yi Q
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886
[TBL] [Abstract] [Full Text] [Related]
4. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/SMAD2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
5. Nanoparticle Targeting in Chemo-Resistant ovarian cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
[TBL] [Abstract] [Full Text] [Related]
7. Loss of B1 and marginal zone B cells during ovarian cancer.
Maslanka J; Torres G; Londregan J; Goldman N; Silberman D; Somerville J; Riggs JE
Cell Immunol; 2024; 395-396():104788. PubMed ID: 38000306
[TBL] [Abstract] [Full Text] [Related]
8. Teratoma pathology and genomics in anti-NMDA receptor encephalitis.
Jang Y; Lee K; Lee C; Chu K; Lee SK; Won JK; Lee ST
Ann Clin Transl Neurol; 2024 Jan; 11(1):225-234. PubMed ID: 37986706
[TBL] [Abstract] [Full Text] [Related]
9. The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
Liu Y; Li Y; Wu Y; Zhao Y; Hu X; Sun C
J Ovarian Res; 2023 Nov; 16(1):219. PubMed ID: 37986114
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
11. Tetrahedral DNA nanostructure enhanced toehold-mediated strand displacement for highly sensitive electrochemiluminescence assay of CA125.
Zhang W; Wang W; Yu Y
Bioelectrochemistry; 2024 Feb; 155():108572. PubMed ID: 37738863
[TBL] [Abstract] [Full Text] [Related]
12. The relationship of lifetime history of depression on the ovarian tumor immune microenvironment.
Hathaway CA; Townsend MK; Conejo-Garcia JR; Fridley BL; Moran Segura C; Nguyen JV; Armaiz-Pena GN; Sasamoto N; Saeed-Vafa D; Terry KL; Kubzansky LD; Tworoger SS
Brain Behav Immun; 2023 Nov; 114():52-60. PubMed ID: 37557966
[TBL] [Abstract] [Full Text] [Related]
13. Metastasis from follicular lymphoma to an ovarian mature teratoma: a case report of tumor-to-tumor metastasis.
Sato Y; Yano M; Eto S; Takano K; Nasu K
J Ovarian Res; 2023 May; 16(1):106. PubMed ID: 37254134
[TBL] [Abstract] [Full Text] [Related]
14. Decreased lamin A and B1 expression results in nuclear enlargement in serous ovarian carcinoma, whereas lamin A-expressing tumor cells metastasize to lymph nodes.
Ouchi M; Kobayashi S; Nishijima Y; Inoue N; Ikota H; Iwase A; Yokoo H; Saio M
Pathol Res Pract; 2023 Jul; 247():154560. PubMed ID: 37229920
[TBL] [Abstract] [Full Text] [Related]
15. Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer.
Bartl T; Alberts A; Papadopoulos SC; Wolf A; Muellauer L; Hofstetter G; Grimm C; Cacsire Castillo-Tong D
Int J Gynecol Cancer; 2023 Sep; 33(9):1419-1426. PubMed ID: 37094966
[TBL] [Abstract] [Full Text] [Related]
16. LILRB1
Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C
Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel.
Dong S; Wang X; Yang S; Guo F; Zhang J; Ji C; Shi L; Cheng Y; Hu Y; Li Z; Peng L; Guo L; Zhu W; Ren X; Yang JM; Zhang Y
Biochem Pharmacol; 2023 May; 211():115533. PubMed ID: 37019189
[TBL] [Abstract] [Full Text] [Related]
18. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
Han GH; Yun H; Chung JY; Kim JH; Cho H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
[TBL] [Abstract] [Full Text] [Related]
19. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
[TBL] [Abstract] [Full Text] [Related]
20. The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells.
Ko SY; Lee W; Weigert M; Jonasch E; Lengyel E; Naora H
J Extracell Vesicles; 2023 Apr; 12(4):e12318. PubMed ID: 36973758
[TBL] [Abstract] [Full Text] [Related]
[Next]
